Search results
Results from the WOW.Com Content Network
6.1 Metabolic disorders and liver diseases. ... also known as perilipin 2, ADRP or adipophilin, ... hypertension accounts many deaths in elderly people. ...
Finerenone, marketed under the brand name Kerendia among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. [8]
Acute use (1–3 days) yields a potency about 1.5× stronger than that of morphine and chronic use (7 days+) yields a potency about 2.5 to 5× that of morphine. Similarly, the effect of tramadol increases after consecutive dosing due to the accumulation of its active metabolite and an increase of the oral bioavailability in chronic use.
In young, healthy volunteers, peak plasma concentrations following a single oral 4 mg immediate-release dose are reached after 1.5 hours. The elimination half-life has been determined as 18.4 hours, and may be prolonged in geriatric patients. After a 4 mg intravenous dose, the elimination half-life is approximately 24 hours.
4) CKD4 (severe) – GFR of 15 to 29 (mL/min)/(1.73 m 2) 5) CKD5 kidney failure – GFR less than 15 (mL/min)/(1.73 m 2) Some people add CKD5D for those stage 5 patients requiring dialysis; many patients in CKD5 are not yet on dialysis. Note: others add a "T" to patients who have had a transplant regardless of stage.
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
About one in ten people have chronic kidney disease. In Canada 1.9 to 2.3 million people were estimated to have CKD in 2008. [69] CKD affected an estimated 16.8% of U.S. adults aged 20 years and older in the period from 1999 to 2004. [102] In 2007 8.8% of the population of Great Britain and Northern Ireland had symptomatic CKD. [103]
Millions of people across the world have kidney disease. Of those millions, several thousand will need dialysis or a kidney transplant at its end-stage. [29] In the United States, as of 2008, 16,500 people needed a kidney transplant. [29] Of those, 5,000 died while waiting for a transplant. [29]